OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
Conditions
Ovarian Neoplasm Epithelial · Fallopian Tube Neoplasms · Ovarian Endometrioid Carcinoma · High-grade Serous Ovarian Carcinoma (HGSOC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Kantonsspital Baden AG, Baden, Canton of Aargau, Switzerland
Universitätsspital Basel, Basel, Canton of Basel-City, Switzerland
Contact: Study coordinator (Viola Heinzelmann-Schwarz, Prof) · viola.heinzelmann@usb.ch · +41 (0)61 265 58 83HOCH Health Ostschweiz Kantonsspital St.Gallen, Sankt Gallen, Canton of St. Gallen, Switzerland
Thurgau AG Frauenfeld / Münsterlingen, Frauenfeld, Thurgau, Switzerland
Inselspital Bern (University Hospital for Medical Oncology), Bern, Switzerland
Contact: Study coordinator (Anke Klingenberg-Rettich) · Anke.Klingenberg-Rettich@insel.ch · +41 (0)31 632 19 28HFR-Fribourg- Hopital Cantonal, Fribourg, Switzerland
Contact: Study coordinator (Vérène Dougoud-Chauvin, Dr. med.) · Verene.Dougoud-Chauvin@h-fr.ch · +41(0)26 306.22 60University Hospital Zurich, Zurich, Switzerland
Contact: Study coordinator (Eleftherios Pierre Samartzis, Dr . med.) · eleftherios.samartzis@usz.ch · +41 (0) 43 253 09 62
Study leads
Viola Heinzelmann-Schwarz, Prof.
Principal Investigator
University Hospital Basel, Head Women's Hospital